<p>Cloud computing is the game changer for the life sciences industry. Globally pharma majors are deploying cloud technology because it provides data security, compliance and transparency, according to Vikram Anand, associate vice president, Cloud-based technology & product delivery services, ArisGlobal.</p><p>"Cloud is changing the way we deploy technology. Eli Lily uses cloud services for research and development efforts. GSK has chosen to replace its existing Lotus Notes, Domino, and Postini services for its 96,500 employees worldwide, with everything being hosted on the Cloud. Roche uses pre-clinical SaaS solution to consolidate several key application areas and harmonize all its sites worldwide," he said.</p><p>The benefits of moving to the Cloud computing is the on-demand delivery of information technology (IT) resources via the Internet with 'pay-as-you-go' pricing. It allows enhanced collaboration, lower upfront investment, provides increased return on investment and greater flexibility and faster scale up of operations.</p><p>For over six years, ArisGlobal has been offering the validated Cloud computing, meeting all requirements specific to life sciences industry. Over 100 life sciences customers on the Cloud and the hosted set-ups aligned with regulatory changes have been successfully audited by regulatory agencies. These cover J&J, AstraZeneca, Alcon and Bausch and Lomb, said Anand at the 6th Regulatory Conference organised by the Drug Information Association (DIA) India.</p><p><a href="http://www.pharmabiz.com/NewsDetails.aspx?aid=75657&sid=1">Keep reading...</a></p>